M32.13
Lung involvement in systemic lupus erythematosus
Clinical Classification Guidelines
Inclusion Terms
- Pleural effusion due to systemic lupus erythematosus
Medical Intelligence & Overview
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple parts of the body. When it involves the lungs, it may lead to various respiratory issues, including inflammation and fluid buildup. The specific ICD-10 code M32.13 relates to lung involvement in SLE, particularly emphasizing pleural effusion caused by this condition. Understanding this aspect of lupus helps in recognizing symptoms, diagnosing, and managing lung-related complications associated with the disease.
Causes & Symptoms
Clinical Causes: Immune system attacking lung tissues due to autoimmune response in SLE Inflammation of the pleura (the thin membrane surrounding the lungs), leading to excess fluid accumulation Autoantibody production resulting in immune complexes that deposit in lung tissues Secondary infections or complications stemming from immunosuppressive treatments
Key Symptoms: Shortness of breath, especially when lying down or during exertion Chest pain, which may worsen with deep breaths or coughing Persistent cough that may be dry or productive Fever and fatigue associated with inflammatory activity Pleural friction rub heard through a stethoscope in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of lung involvement in SLE often involves a combination of patient history, physical examination, and various tests. Key diagnostic steps include:
Treatment Protocols: Managing lung involvement in SLE focuses on controlling inflammation, preventing complications, and alleviating symptoms. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M32.13 a billable ICD-10 code?
Yes, M32.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M32.13?
Clinical documentation must specify the nature of Lung involvement in systemic lupus erythematosus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference